Click here to emailClick here to printClick here to share

Personalized Medicine

 

Mapping a Way through the Double Helix: Making sense of personalized medicine for Ontario’s cancer system

December 8, 2010 – The event focused on decision-making models and approval frameworks for molecular testing and treatment therapies in personalized medicine as well as the supports required for healthcare providers and patients for assist with decisions at point of care. The event also identified the ethical, social and legal implications of genomics and the policy required to support the appropriate use of personalized medicine in Ontario.